On May 24, 2024, Applied UV, Inc. and its subsidiary SteriLumen, Inc. filed for Chapter 11 bankruptcy in the United States Bankruptcy Court for the District of New York. The filings, which allow the companies to continue operating as debtors-in-possession, are aimed at enabling them to maintain ordinary business operations during the restructuring process. Applied UV, Inc. has also received a Delisting Notice from The Nasdaq Stock Market LLC, indicating that its common stock and Series A Preferred Stock will be delisted due to the bankruptcy filings and related public interest concerns. The delisting will take effect at the opening of business on June 4, 2024. The company has chosen not to appeal the delisting decision. Applied UV cautions that trading in its stocks is highly speculative and risky, as the outcome of the bankruptcy proceedings and the potential recovery for stockholders are uncertain.

On May 24, 2024, Applied UV, Inc. and its subsidiary SteriLumen, Inc. filed for Chapter 11 bankruptcy in the United States Bankruptcy Court for the District of New York. The filings, which allow the companies to continue operating as debtors-in-possession, are aimed at enabling them to maintain ordinary business operations during the restructuring process. Applied UV, Inc. has also received a Delisting Notice from The Nasdaq Stock Market LLC, indicating that its common stock and Series A Preferred Stock will be delisted due to the bankruptcy filings and related public interest concerns. The delisting will take effect at the opening of business on June 4, 2024. The company has chosen not to appeal the delisting decision. Applied UV cautions that trading in its stocks is highly speculative and risky, as the outcome of the bankruptcy proceedings and the potential recovery for stockholders are uncertain.